181 related articles for article (PubMed ID: 27833920)
1. miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis.
Xin Y; Cai H; Lu T; Zhang Y; Yang Y; Cui Y
Biomed Res Int; 2016; 2016():9595718. PubMed ID: 27833920
[No Abstract] [Full Text] [Related]
2. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774
[TBL] [Abstract][Full Text] [Related]
4. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
Cron MA; Guillochon É; Kusner L; Le Panse R
Front Immunol; 2020; 11():1074. PubMed ID: 32587589
[TBL] [Abstract][Full Text] [Related]
6. LncRNA XLOC_003810 promotes T cell activation and inhibits PD-1/PD-L1 expression in patients with myasthenia gravis-related thymoma.
Hu B; Niu L; Jiang Z; Xu S; Hu Y; Cao K
Scand J Immunol; 2020 Jul; 92(1):e12886. PubMed ID: 32243615
[TBL] [Abstract][Full Text] [Related]
7. Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report.
Tajima S; Yanagiya M; Sato M; Nakajima J; Fukayama M
Int J Clin Exp Pathol; 2015; 8(11):15375-80. PubMed ID: 26823897
[TBL] [Abstract][Full Text] [Related]
8. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific signature of serum miR-20b and its targets IL-8 and IL-25, in myasthenia gravis patients.
Chunjie N; Huijuan N; Zhao Y; Jianzhao W; Xiaojian Z
Eur Cytokine Netw; 2015 Sep; 26(3):61-6. PubMed ID: 26845056
[TBL] [Abstract][Full Text] [Related]
10. miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice.
Shi L; Liu T; Zhang M; Guo Y; Song C; Song D; Liu H
Med Sci Monit; 2015 Jun; 21():1774-80. PubMed ID: 26087886
[TBL] [Abstract][Full Text] [Related]
11. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
Park SL; Cho TM; Won SY; Song JH; Noh DH; Kim WJ; Moon SK
Oncol Rep; 2015 Sep; 34(3):1605-12. PubMed ID: 26166554
[TBL] [Abstract][Full Text] [Related]
13. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
15. Effect of miR-20b on Apoptosis, Differentiation, the BMP Signaling Pathway and Mitochondrial Function in the P19 Cell Model of Cardiac Differentiation In Vitro.
Zhu S; Hu X; Yu Z; Peng Y; Zhu J; Liu X; Li M; Han S; Zhu C
PLoS One; 2015; 10(4):e0123519. PubMed ID: 25898012
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma.
Takahashi K; Monden Y; Saito S; Kamamura Y; Uyama T
J Clin Immunol; 1996 Jul; 16(4):190-7. PubMed ID: 8840220
[TBL] [Abstract][Full Text] [Related]
17. Muscle lymphocytic infiltrates in thymoma-associated myasthenia gravis are phenotypically different from those in polymyositis.
Zamecnik J; Vesely D; Jakubicka B; Simkova L; Pitha J; Schutzner J; Mazanec R; Vogel H
Neuromuscul Disord; 2007 Dec; 17(11-12):935-42. PubMed ID: 17651972
[TBL] [Abstract][Full Text] [Related]
18. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
20. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
